Press release
At a CAGR of 7.3%, Thalassemia Treatment Market Size will Estimated to Worth USD 1.5 Billion by 2031 | TMR Research
Thalassemia Treatment Market
Thalassemia Treatment Market (지중해 빈혈 치료 시장) is expected to increase at a CAGR of 7.3% from 2023 to 2031 and reach US$ 1.5 Bn by the end of 2031
Request a PDF Sample of this Report Now!
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=44462
Overview of Thalassemia Treatment Market
The global thalassemia treatment market is experiencing significant growth due to increasing awareness, early diagnosis, and advancements in treatment options. The market is segmented by treatment type (blood transfusions, iron chelation therapy, bone marrow transplantation, gene therapy, others), patient type (alpha thalassemia, beta thalassemia), end user (hospitals, specialty clinics, research institutes), and geographical regions.
Top Companies:
Bluebird Bio, Inc.
Merck & Co., Inc.
Novartis AG
Celgene Corporation
Takeda Pharmaceuticals Company Limited
Incyte Corporation
Sanofi
Bellicum Pharmaceuticals
GSK plc
Others
Recent Developments in Thalassemia Treatment Market
Recent advancements and trends in the thalassemia treatment market include:
Gene Therapy: Development of gene therapy treatments, such as LentiGlobin, offering the potential for a curative approach by correcting the genetic defect causing thalassemia.
Novel Iron Chelators: Introduction of new and more effective iron chelators with improved safety profiles and patient compliance, such as Deferasirox and Deferiprone.
Advanced Diagnostics: Enhanced diagnostic techniques, including prenatal genetic testing and advanced imaging, enabling early and accurate diagnosis of thalassemia.
Supportive Therapies: Innovations in supportive therapies, such as erythropoiesis-stimulating agents, to manage anemia and improve patient outcomes.
Patient-centric Care: Growing emphasis on patient-centric care models, integrating multidisciplinary approaches to manage the various aspects of thalassemia.
Drivers of Market Growth
Several factors contribute to the growth of the thalassemia treatment market:
Increasing Prevalence: Rising prevalence of thalassemia, particularly in regions with high carrier rates, driving the demand for effective treatment options.
Technological Advancements: Continuous advancements in genetic research and therapeutic technologies enhancing treatment efficacy and safety.
Awareness and Screening: Increasing awareness and implementation of screening programs for early detection and management of thalassemia.
Healthcare Infrastructure: Improvement in healthcare infrastructure, especially in developing countries, facilitating better access to thalassemia treatments.
Government Initiatives: Government initiatives and funding to support research, treatment, and management of thalassemia.
Unlock Growth Potential in Your Industry! Download PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=44462
Conclusion
The thalassemia treatment market is poised for significant growth, driven by increasing prevalence, technological advancements, awareness and screening programs, improved healthcare infrastructure, and government initiatives. Innovations in gene therapy, novel iron chelators, advanced diagnostics, supportive therapies, and patient-centric care models are enhancing the treatment landscape.
Market Segmentation
Treatment Type
Blood Transfusion
Chelation Therapy
Bone Marrow Transplantation
Others
Regions Covered
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=44462<ype=S
More Trending Reports by Transparency Market Research -
Urinary Tract Disorders Propels Ureteral Stents Market (尿路疾患が尿管ステント市場を牽引): https://www.globenewswire.com/news-release/2024/07/05/2909009/32656/en/Rising-Incidence-of-Urinary-Tract-Disorders-Propels-Ureteral-Stents-Market-to-Achieve-USD-823-7-Million-by-2031-Transparency-Market-Research-Inc.html
Cryotherapy Market (Marché de la cryothérapie): https://www.globenewswire.com/en/news-release/2024/07/03/2908096/32656/en/Cryotherapy-Market-to-be-Worth-USD-885-7-million-by-2034-Growing-a-CAGR-9-3-Exclusive-Report-by-Transparency-Market-Research-Inc.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release At a CAGR of 7.3%, Thalassemia Treatment Market Size will Estimated to Worth USD 1.5 Billion by 2031 | TMR Research here
News-ID: 3610557 • Views: …
More Releases from Transparency Market Research
Neuromorphic Chip Market to Reach USD 2.3 Billion by 2034, Driven by Explosive A …
The global Neuromorphic Chip Market is entering a defining phase of exponential growth, propelled by a surge in artificial intelligence (AI) applications, edge computing expansion, and rapid advancements in next-generation semiconductor technologies. According to the latest industry analysis, the market-valued at US$ 56.2 Mn in 2023-is projected to expand at an extraordinary CAGR of 40.1% from 2024 to 2034, reaching an estimated US$ 2.3 Bn by 2034.
Examine key highlights and…
Neuroprotection Market Surges Toward USD 60.1 Bn by 2031 as Global Neurological …
The global Neuroprotection Market continues to gain unprecedented momentum as healthcare systems worldwide intensify their focus on combating neurological disorders. With a valuation of US$ 31.6 Bn in 2022, the market is on track to reach US$ 60.1 Bn by 2031, expanding at a robust 7.5% CAGR during the forecast period. The rise in dementia, stroke, Parkinson's, epilepsy, and multiple sclerosis-combined with aging demographics and a surge in sedentary lifestyles-has…
Neuroregeneration Therapy Market Set to Reach USD 64.8 Bn by 2034, Driven by Inn …
The global neuroregeneration therapy market continues to chart steady, sustained growth. The increasing incidence of neurological disorders-including Alzheimer's disease, Parkinson's disease, multiple sclerosis, Huntington's disease, stroke, diabetic neuropathy, and spinal cord injuries-is significantly influencing market expansion. In 2023, the market was worth US$ 37.0 Bn, demonstrating rising demand for treatments capable of repairing or regenerating damaged neural tissue.
Examine key highlights and takeaways from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86322
With breakthroughs…
Neuroscience Market Set to Reach USD 41.6 Bn by 2031 Driven by Technological Adv …
The global neuroscience market stood at US$ 30.1 Bn in 2022, reflecting the significant technological and clinical potential of neurological research. Projected to grow at a CAGR of 3.7% from 2023 to 2031, the industry is expected to reach US$ 41.6 Bn by 2031. Rising prevalence of neurodegenerative diseases, advancements in neuroimaging, integration of artificial intelligence, and the emergence of brain-computer interfaces are shaping the next decade of neuroscience innovation.
Examine…
More Releases for Thalassemia
Thalassemia Market to Reach USD 9.1 Billion by 2034
The Thalassemia Market is entering a critical phase of expansion as healthcare systems worldwide focus on rare genetic blood disorders. Thalassemia, an inherited hemoglobin disorder, requires lifelong management through blood transfusions, iron chelation therapy, and, in some cases, curative bone marrow transplantation or emerging gene therapies. With the rising global prevalence, especially in Asia-Pacific and the Mediterranean regions, the market is seeing strong demand for innovative treatments and supportive care…
Global Thalassemia Market Size – Forecast to 2026
The findings reviewed by GME stated that the Global Thalassemia Market will expand with a CAGR value of 10.2 percent from 2021 to 2026. Several drivers are likely to accelerate the thalassemia market further, including an increasing occurrence of thalassemia, growing public awareness, expanding expenditure in research & development, and the growing need for improved curative gene therapy.
Browse 159 Market Data Tables and 119 Figures spread through 189 Pages and…
Thalassemia Market to witness steady growth increase by 2024
Zion Market Research analysts forecast the latest report on "Thalassemia Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016-2024", according to their latest report the Thalassemia Market report covers the overall and all-inclusive analysis of the Thalassemia Market with all its factors that have an impact on market growth. The Thalassemia Market's complete outline is crystal clear penned down in the global Thalassemia Market research report such that…
Thalassemia Treatment Market is driven by increase in number of altered thalasse …
Thalassemia Treatment Market - Snapshot
The global thalassemia treatment market is driven by increase in number of altered thalassemia genes across the globe. The global market was valued at US$ 842.0 Mn in 2017 and is projected to expand at a CAGR of 7.9% from 2018 to 2026 to reach US$ 1,639.6 Mn by 2026. The global market is witnessing high growth owing to increase in blood transfusion and chelation therapy…
Thalassemia - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Thalassemia - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thalassemia - Pipeline Review, H1 2017, provides an overview of the Thalassemia (Hematological Disorders) pipeline landscape.
Thalassemia is a group of inherited blood disorders that affect the body's ability to produce hemoglobin and red blood cells. Symptoms…
Global Thalassemia Market Report: 2016 Edition
Thalassemia is a hereditary blood disorder in which a person’s body makes an abnormal form of hemoglobin, which is the protein molecule in red blood cells (RBCs), which carries oxygen. The disorder results in unwarranted damage of red blood cells, which leads to anemia. Anemia is a condition in which the body doesn’t have adequate amount of normal and healthy red blood cells. There are majorly two types of thalassemia…
